Breaking into new grounds: Orthocell eyes $75M Canadian market with game-changing nerve repair product
In a bold move to capture a significant share of the global nerve repair market, Orthocell, a pioneer in regenerative medicine, has submitted a regulatory application to Health Canada for its leading product, Remplir. This step marks a strategic expansion into the Canadian market, valued at approximately US$75 million, with approvals anticipated in the latter…